Cafepharma Today

February 6 2025 - Bristol Myers Squibb tops Q4 estimates
Bristol Myers Squibb tops Q4 estimates
AstraZeneca bounds higher on Q4 beat, upbeat guidance
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Pfizer taps a former Novartis exec to lead cancer drug push
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

[video]Mad About Options: The Baxter Bunker
TheStreet.com
Wednesday, March 11, 2009 - 8:55am
tags:
Baxter International
Marcial: Could J&J Make a Run at Schering-Plough?
Businessweek
Wednesday, March 11, 2009 - 8:55am
tags:
JNJ, Schering Plough
Four Weighty Reasons to Invest in Vivus
Seeking Alpha
Wednesday, March 11, 2009 - 7:50am
tags:
Vivus, Qnexa, obesity
Top Pain Scientist Fabricated Data in Studies, Hospital Says
WSJ Online
Wednesday, March 11, 2009 - 7:39am
tags:
Wyeth, Vioxx, Pfizer, Merck, Celebrex
Drug-firm mergers can slow research
Philadelphia Inquirer, PA
Wednesday, March 11, 2009 - 7:37am
tags:
R&D, buyouts
Ferring introduces new prostate cancer drug in US
Pharmaceutical Business Review
Wednesday, March 11, 2009 - 7:14am
tags:
Ferring, prostate cancer, FDA
Closing My Emergent BioSolutions Position
Seeking Alpha
Wednesday, March 11, 2009 - 7:13am
tags:
Emergent BioSolutions
When Will the Genentech Roller Coaster End?
Seeking Alpha
Wednesday, March 11, 2009 - 6:04am
tags:
Genentech, Roche, buyouts
Geron: The Excitement is Back
Seeking Alpha
Wednesday, March 11, 2009 - 6:02am
tags:
Geron, stem cells
Pfizer Cancer Campaign Persuades U.K. to Pay for Drug
Bloomberg
Wednesday, March 11, 2009 - 6:01am
tags:
Pfizer, UK, cancer, Sutent
Schering-Plough, Merck Have $1.25 Billion Breakup Fee
Bloomberg
Wednesday, March 11, 2009 - 6:00am
tags:
Merck, Schering Plough, buyouts
Consolidation is key to pharma stability
FT.com
Wednesday, March 11, 2009 - 5:59am
tags:
buyouts, Merck, Roche, Genentech, Pfizer, Wyeth, Schering Plough
J&J Potential Hitch in Merck-Schering's Get-Along
TheStreet.com
Tuesday, March 10, 2009 - 3:47pm
tags:
JNJ, buyouts, Merck, Schering Plough, Remicade, rheumatoid arthritis
Pharma: Are Mega Mergers Good for Business?
Seeking Alpha
Tuesday, March 10, 2009 - 3:46pm
tags:
Big Pharma, buyouts, Genentech, Eli Lilly, Merck, Pfizer, Roche, Wyeth, Schering Plough
AstraZeneca challenges witnesses in Seroquel suit
Yahoo/AP
Tuesday, March 10, 2009 - 3:44pm
tags:
AstraZeneca, Seroquel, antipsychotics
Schering Leak Likely as Options Jumped
TheStreet.com
Tuesday, March 10, 2009 - 3:43pm
tags:
Schering Plough, Merck, buyouts
[video]Shareholders' next move and other pharma targets
Yahoo/Morningstar
Tuesday, March 10, 2009 - 3:42pm
tags:
Merck, Schering Plough, buyouts
Analysts say reluctant Lilly is merger candidate
Indianapolis Star, IN
Tuesday, March 10, 2009 - 10:33am
tags:
Eli Lilly, buyouts
Roche says latest Genentech bid is still fair
Yahoo/Reuters
Tuesday, March 10, 2009 - 10:31am
tags:
Genentech, Roche, buyouts
Eurand's ulcerative colitis drug candidate for children gets FDA orphan drug status
Yahoo/AP
Tuesday, March 10, 2009 - 10:30am
tags:
FDA, ulcerative colitis, Aptalis

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information